This 12-minute presentation was given by Vamsee Pamula, Co-Founder & President of Baebies, in an online forum hosted by Medical Lab Observer (MLO). Watch the webinar to learn how digital microfluidics enables ultra-rapid thermocycling for PCR.
This presentation was given by Vamsee Pamula in a livestream on August 4, 2020 hosted by the PAS Summer Webinar Series – Neonatal Infectious Diseases I – regarding the performance of cCMV PCR assays in a disposable cartridge in a completely automated fashion to enable in-hospital screening.
This presentation was given by Dr. Michael Cotten in a livestream on July 24, 2020 hosted by the PAS Summer Webinar Series – Neonatal Hematology & Bilirubin Metabolism regarding the evaluation of a G6PD testing platform that uses 50 µL whole blood samples with turn-around time of 15 minutes.
Watch this recorded webinar with Jon Washburn, Staff Engineer at Baebies, as he discusses causes of positive newborn screening results for lysosomal storage disorders (LSDs) and ways to reduce false positives by optimizing first tier enzyme testing cutoffs and integrating second tier screening.
This presentation was given by Dr. Namasivayam Ambalavanan in a livestream on May 4, 2020 hosted by the Neonatal Kidney Collaborative. Due to the cancellation of PAS 2020 related to COVID-19, Baebies has developed this accessible presentation, derived from the accepted abstract.
Dr. Priya Kishnani, advocate and expert on Pompe Disease, summarizes the diverse clinical presentations of both the infantile and late-onset of Pompe Disease. Her webinar also accentuates the significant difference that early screening and diagnosis can make in a patient’s outcome.
In this webinar, Dr. Priya Kishnani, Professor of Pediatrics and Chief of the Division of Medical Genetics at Duke, emphasizes the necessity to identify Pompe Disease early through NBS (newborn screening). Dr. Kishnani mentions the significant benefits to beginning ERT (enzyme replacement therapy) as soon as possible and how responsiveness to therapy changes with age and severity of condition onset.